NX PharmaGen's Debt Round

NX PharmaGen raised a round of funding on June 25, 2013.

NX PharmaGen acquires, develops, and monetizes mature clinical-stage technologies. The company's lead program is a disruptive diagnostic technology, termed the NeXosome Platform. Through its wholly-ow…

Articles about NX PharmaGen's Debt Round: